Literature DB >> 32396849

Control of Platelet CLEC-2-Mediated Activation by Receptor Clustering and Tyrosine Kinase Signaling.

Alexey A Martyanov1, Fedor A Balabin2, Joanne L Dunster3, Mikhail A Panteleev4, Jonathan M Gibbins3, Anastasia N Sveshnikova5.   

Abstract

Platelets are blood cells responsible for vascular integrity preservation. The activation of platelet receptor C-type lectin-like receptor II-type (CLEC-2) could partially mediate the latter function. Although this receptor is considered to be of importance for hemostasis, the rate-limiting steps of CLEC-2-induced platelet activation are not clear. Here, we aimed to investigate CLEC-2-induced platelet signal transduction using computational modeling in combination with experimental approaches. We developed a stochastic multicompartmental computational model of CLEC-2 signaling. The model described platelet activation beginning with CLEC-2 receptor clustering, followed by Syk and Src family kinase phosphorylation, determined by the cluster size. Active Syk mediated linker adaptor for T cell protein phosphorylation and membrane signalosome formation, which resulted in the activation of Bruton's tyrosine kinase, phospholipase and phosphoinositide-3-kinase, calcium, and phosphoinositide signaling. The model parameters were assessed from published experimental data. Flow cytometry, total internal reflection fluorescence and confocal microscopy, and western blotting quantification of the protein phosphorylation were used for the assessment of the experimental dynamics of CLEC-2-induced platelet activation. Analysis of the model revealed that the CLEC-2 receptor clustering leading to the membrane-based signalosome formation is a critical element required for the accurate description of the experimental data. Both receptor clustering and signalosome formation are among the rate-limiting steps of CLEC-2-mediated platelet activation. In agreement with these predictions, the CLEC-2-induced platelet activation, but not activation mediated by G-protein-coupled receptors, was strongly dependent on temperature conditions and cholesterol depletion. Besides, the model predicted that CLEC-2-induced platelet activation results in cytosolic calcium spiking, which was confirmed by single-platelet total internal reflection fluorescence microscopy imaging. Our results suggest a refined picture of the platelet signal transduction network associated with CLEC-2. We show that tyrosine kinase activation is not the only rate-limiting step in CLEC-2-induced activation of platelets. Translocation of receptor-agonist complexes to the signaling region and linker adaptor for T cell signalosome formation in this region are limiting CLEC-2-induced activation as well.
Copyright © 2020 Biophysical Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32396849      PMCID: PMC7264845          DOI: 10.1016/j.bpj.2020.04.023

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  70 in total

Review 1.  The Src, Syk, and Tec family kinases: distinct types of molecular switches.

Authors:  J Michael Bradshaw
Journal:  Cell Signal       Date:  2010-03-04       Impact factor: 4.315

Review 2.  New fundamentals in hemostasis.

Authors:  Henri H Versteeg; Johan W M Heemskerk; Marcel Levi; Pieter H Reitsma
Journal:  Physiol Rev       Date:  2013-01       Impact factor: 37.312

3.  Interspecies differences in protein expression do not impact the spatiotemporal regulation of glycoprotein VI mediated activation.

Authors:  Joanne L Dunster; Amanda J Unsworth; Alexander P Bye; Elizabeth J Haining; Marcin A Sowa; Ying Di; Tanya Sage; Chiara Pallini; Jeremy A Pike; Alexander T Hardy; Bernhard Nieswandt; Ángel García; Steve P Watson; Natalie S Poulter; Jonathan M Gibbins; Alice Y Pollitt
Journal:  J Thromb Haemost       Date:  2019-12-06       Impact factor: 5.824

4.  The N-terminal SH2 domain of Syk is required for (hem)ITAM, but not integrin, signaling in mouse platelets.

Authors:  Craig E Hughes; Brenda A Finney; Frank Koentgen; Kate L Lowe; Steve P Watson
Journal:  Blood       Date:  2014-10-28       Impact factor: 22.113

5.  Molecular analysis of the pathophysiological binding of the platelet aggregation-inducing factor podoplanin to the C-type lectin-like receptor CLEC-2.

Authors:  Yukinari Kato; Mika Kato Kaneko; Akiko Kunita; Hiromi Ito; Akihiko Kameyama; Satoshi Ogasawara; Nana Matsuura; Yasushi Hasegawa; Katsue Suzuki-Inoue; Osamu Inoue; Yukio Ozaki; Hisashi Narimatsu
Journal:  Cancer Sci       Date:  2007-10-18       Impact factor: 6.716

6.  CLEC-2 activates Syk through dimerization.

Authors:  Craig E Hughes; Alice Y Pollitt; Jun Mori; Johannes A Eble; Michael G Tomlinson; John H Hartwig; Christopher A O'Callaghan; Klaus Fütterer; Steve P Watson
Journal:  Blood       Date:  2010-02-12       Impact factor: 22.113

7.  The platelet receptor CLEC-2 is active as a dimer.

Authors:  Aleksandra A Watson; Charita M Christou; John R James; Angharad E Fenton-May; Gerald E Moncayo; Anita R Mistry; Simon J Davis; Robert J C Gilbert; Aron Chakera; Chris A O'Callaghan
Journal:  Biochemistry       Date:  2009-11-24       Impact factor: 3.162

8.  Crystal structure of rhodocytin, a ligand for the platelet-activating receptor CLEC-2.

Authors:  Aleksandra A Watson; Johannes A Eble; Chris A O'Callaghan
Journal:  Protein Sci       Date:  2008-06-26       Impact factor: 6.725

9.  Diffusion of GPI-anchored proteins is influenced by the activity of dynamic cortical actin.

Authors:  Suvrajit Saha; Il-Hyung Lee; Anirban Polley; Jay T Groves; Madan Rao; Satyajit Mayor
Journal:  Mol Biol Cell       Date:  2015-09-16       Impact factor: 4.138

10.  Quantitative dynamics of reversible platelet aggregation: mathematical modelling and experiments.

Authors:  Aleksandra A Filkova; Alexey A Martyanov; Andrei K Garzon Dasgupta; Mikhail A Panteleev; Anastasia N Sveshnikova
Journal:  Sci Rep       Date:  2019-04-17       Impact factor: 4.379

View more
  3 in total

1.  Ex vivo observation of granulocyte activity during thrombus formation.

Authors:  Daria S Morozova; Alexey A Martyanov; Sergei I Obydennyi; Julia-Jessica D Korobkin; Alexey V Sokolov; Ekaterina V Shamova; Irina V Gorudko; Anna L Khoreva; Anna Shcherbina; Mikhail A Panteleev; Anastasia N Sveshnikova
Journal:  BMC Biol       Date:  2022-02-07       Impact factor: 7.431

Review 2.  ASGR1 and Its Enigmatic Relative, CLEC10A.

Authors:  J Kenneth Hoober
Journal:  Int J Mol Sci       Date:  2020-07-08       Impact factor: 5.923

3.  Longitudinal multiparametric characterization of platelet dysfunction in COVID-19: Effects of disease severity, anticoagulation therapy and inflammatory status.

Authors:  Alexey A Martyanov; Anna E Boldova; Maria G Stepanyan; Olga I An; Alexander S Gur'ev; Darya V Kassina; Alexey Y Volkov; Alexandr V Balatskiy; Andrei A Butylin; Sergei S Karamzin; Elena V Filimonova; Sergei V Tsarenko; Sergei A Roumiantsev; Alexander G Rumyantsev; Mikhail A Panteleev; Fazoil I Ataullakhanov; Anastasia N Sveshnikova
Journal:  Thromb Res       Date:  2022-01-15       Impact factor: 3.944

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.